Results 101 to 110 of about 862,336 (259)

Correspondence on “First year result and insights from the Mexican Rare Disease Patient Registry from Cesar E. Calvo Aspiros and Claudia Gonzaga-Jauregui

Rare
Marcela Vela-Amieva, Cynthia Fernández-Lainez   +1 more
doaj   +1 more source

Exploring the potential impact of medical errors research on population health. [PDF]

PLoS One
Sarquis Rivera MA, Hernandez-Paez DA, Galván-Barrios J, Barceló-Martinez E, Narvaez-Rojas AR, Lozada-Martinez ID.   +5 more
europepmc   +1 more source

Frailty Exacerbates Disability in Progressive Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks, Anna Wolska, Diala Ghazal, Dejan Jakimovski, Bianca Weinstock‐Guttman, Alexander Burnham, Niels Bergsland, Michael G. Dwyer, Alan T. Remaley, Robert Zivadinov, Murali Ramanathan   +10 more
wiley   +1 more source

General Aspects of Identification, Prevention, and Protection From Medical Errors in Radiation Oncology. [PDF]

Cureus
Živković Radojević M, Bosnjakovic K, Milosavljević N, Grujic M, Todorovic M.   +4 more
europepmc   +1 more source

Causes for Medical Errors in Obstetrics and Gynaecology. [PDF]

Healthcare (Basel), 2023
Klemann D, Rijkx M, Mertens H, van Merode F, Klein D.   +4 more
europepmc   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Enhancing Coping and Communication Strategies Following Medical Errors: A Video Case Scenario Workshop for Pediatric Residents. [PDF]

MedEdPORTAL
Rao U, Payne C, Zieve H, Lucas CT, Shekarabi N, Vasa M, Afghani B.   +6 more
europepmc   +1 more source

Medical Errors

AMA Journal of Ethics, 2002
openaire   +2 more sources

Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai, Yang Qu, Reziya Abuduxukuer, Kejia Zhang, Peng Zhang, Xin Tang, Huaimei Zhang, Lijuan Wang, Lichong Yang, Shuangxu Tan, Zhimei Yuan, Ce Han, Lili He, Yuping Zheng, Fenglan Zhao, Lijie Guo, Ligang Jiang, Jinfeng Li, Yongfei Jiang, Xuexia Zou, Dan Xu, Han Xu, Xiaojia Wang, Yingbin Qi, Xuefeng Hu, Yu Zhang, Zhen‐Ni Guo, Hang Jin, on behalf of the Biomarkers of Brain Injury Investigator Study Group   +28 more
wiley   +1 more source

Intention to disclose medical errors by healthcare providers to patients and associated factors in Ugandan health facilities: A cross-sectional study. [PDF]

PLOS Glob Public Health
Alupo C, Izudi J, Ddamulira C.
europepmc   +1 more source